Skip to content

Clinical trials

Lymphoma, B-Cell, Marginal Zone trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Country / region: Poland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20132
20141
20161
20171
20181
20193
20213
20223
20233
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting7
Terminated5
Active, not recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Eli Lilly and Company2
Incyte Corporation2
MEI Pharma, Inc.2
Regeneron Pharmaceuticals2
BeOne Medicines1
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1
Genmab1
Hutchmed1
International Extranodal Lymphoma Study Group (IELSG)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone24
Lymphoma, Follicular19
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, Mantle-Cell11
Waldenstrom Macroglobulinemia11
Lymphoma, Non-Hodgkin9
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, B-Cell5
Lymphoma4
Recurrence3

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.